Spending on cancer drugs in the United States has now exceeded $56 billion and the median annual cost of a new cancer...
Prior Authorizations are designed to ensure that patients receive the right care at the right time, and in the most...
In part two of this four-part series from our webinar “The Evolution of Value-Based Care: A Shift to Patient-Centric Care,”...
Continued Relationships with Health Insurers Reflect the Need for High-quality, High-value Care as Cancer Treatments Become Increasingly Complex Culver City,...
In 2018, spending on cancer drugs in the United States has more than doubled since 2013 and has now exceeded...
Knowledgeable, caring, inspiring, a great leader, and mentor. These are the words used to describe Eviti Senior Director of Clinical...
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...